You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NGNE Sale Disclosure
Cvijic Christine Mikail · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$25.17K
Cvijic Christine Mikail President And CFO
NGNE
Neurogene
NGNE
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
NGNE daily price context
Close on/before transaction
$33.88
Jul 1, 2026
First close after public filing
$32.56
Jul 6, 2026
30-day return after filing
+0.95%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 739 shares @ $34.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001543663-26-000015
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$166.59K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurogene Inc. NGNE | Sale | Jul 2, 2026 | $87.52K |
| Neurogene Inc. NGNE | Sale | Jul 2, 2026 | $53.9K |
| Neurogene Inc. NGNE Current | Sale | Jul 1, 2026 | $25.17K |